Pfizer PFE Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Pfizer’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pfizer's change in AR?
- Pfizer (PFE) reported change in AR of $65.75M in Q4 2025.
- How has Pfizer's change in AR changed year-over-year?
- Pfizer's change in AR increased by 141.3% year-over-year, from $27.25M to $65.75M.
- What is the long-term trend for Pfizer's change in AR?
- Over 4 years (2021 to 2025), Pfizer's change in AR has grown at a -48.7% compound annual growth rate (CAGR), from $3.81B to $263M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.